Target intelligence / Profile preview

Pathogenic bacteria adhesin (None established; commonly referred to as "adhesin" or "bacterial adhesin")

Target
None established; commonly referred to as "adhesin" or "bacterial adhesin"
Molecular classification
Other (surface protein/appendage), Virulence factor, In some cases, classified by structure: fimbriae/pili (fimbrial), non-fimbrial proteins, polysaccharide layers
01

Overview

Bacterial adhesins are specialized surface proteins or appendages found on pathogenic bacteria that mediate strong and specific binding to receptors on host cells or tissues. This interaction is essential for initiating infection because it allows bacteria to overcome physical forces such as fluid flow and immune clearance mechanisms within the host environment. Adhesion is often mediated by structures like pili/fimbriae in Gram-negative bacteria—where tip proteins act as actual ligands—or by cell wall-associated proteins/polysaccharides in Gram-positive species. These molecules confer tissue specificity ("tropism") and play critical roles not only in initial colonization but also biofilm formation and persistence during infection. Because disrupting this interaction can prevent infection without killing the bacterium directly—a strategy less likely to drive resistance—bacterial adhesins have become attractive targets for new antimicrobial therapies focused on blocking pathogen-host interactions rather than traditional bactericidal/bacteriostatic approaches.

Other names
Bacterial adhesion proteinAdhesion factorMicrobial surface component recognizing adhesive matrix molecules (MSCRAMMs)Fimbrial adhesinNon-fimbrial adhesin
02

Mechanism of action

Competitive inhibition/blockade of the binding site on the bacterial adhesin or its host receptor to prevent attachment and colonization ("antiadhesion therapy")

03

Biological functions

Host cell attachment/adherenceColonization of host tissuesBiofilm formationEvasion of physical removal by host defenses
04

Disease associations

Infection (broadly across bacterial pathogens)Urinary tract infections (*E. coli* FimH)Respiratory infections (*Bordetella pertussis*, *Staphylococcus aureus*)Plant diseases (*Xanthomonas*, *Xylella*)
05

Safety considerations

Redundancy/multiplicity of different types of adhesins expressed by pathogens, making single-target approaches less effective.Risk that blocking adhesion could select for alternative virulence mechanisms.No major direct safety concerns identified with antiadhesion strategies so far, but efficacy remains a challenge due to pathogen diversity and adaptability.
06

Interacting drugs

No approved drugs directly target bacterial adhesins in clinical use yet, but antiadhesion therapies and compounds that block these interactions are under investigation as novel antimicrobial strategies.

1 more in the full profile.

07

Biomarkers

None established for clinical use; presence/expression level of specific bacterial adhesins may serve as biomarkers in research settings.

Beyond the preview

Go deeper on Pathogenic bacteria adhesin (None established; commonly referred to as "adhesin" or "bacterial adhesin").

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria adhesin (None established; commonly referred to as "adhesin" or "bacterial adhesin").

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call